What is the Anuh Pharma PE ratio today?
Anuh Pharma's PE ratio is 18.1 at the 29 October 2026 close (₹79.74 a share): a market capitalisation of ₹799 crore divided by consolidated net profit of ₹44.2 crore over the last four quarters (Q2 FY26 to Q1 FY27). On FY26 net profit (₹41 crore) it is 19.5.
What is the Anuh Pharma PB ratio (price to book value)?
Anuh Pharma's price-to-book (PB) ratio is 2.27 at the 29 October 2026 close: a market capitalisation of ₹799 crore divided by shareholders' equity (book value) of ₹352 crore on 31 March 2026. That is a book value of ₹35.14 per share against a share price of ₹79.74.
What is the Anuh Pharma net worth?
Anuh Pharma's net worth — shareholders' equity in its consolidated balance sheet — was ₹352 crore on 31 March 2026, up 8.0% from ₹326 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹799 crore at the 29 October 2026 close.
What is the Anuh Pharma market cap?
Anuh Pharma's market capitalisation was ₹799 crore at the 29 October 2026 close: 10.02 crore shares at ₹79.74 each.
Is Anuh Pharma debt free?
Yes. Anuh Pharma had no borrowings on 31 March 2026 (consolidated balance sheet), and it held ₹53.2 crore of cash, bank balances and current investments.
What is the Anuh Pharma debt to equity ratio?
Anuh Pharma's debt-to-equity ratio was 0.00 on 31 March 2026: no borrowings against total equity of ₹352 crore. A year earlier, on 31 March 2025, it was 0.03.
What is the Anuh Pharma ROE and ROCE?
In FY26, Anuh Pharma's return on equity (ROE) was 12.1% and its return on capital employed (ROCE) was 14.8%. ROE is net profit divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities).
What is the Anuh Pharma shareholding pattern?
On 30 September 2026, Anuh Pharma's shares were held by promoters 71.80%, foreign portfolio investors (FII/FPI) 0.11%, domestic institutions (DII) 0.00% (including mutual funds at 0.00%) and retail and other non-institutional investors 28.09%. Over the year, FII holding was up 0.11 percentage points from 0.00% and DII holding was unchanged.
What is the Anuh Pharma free cash flow?
In FY26, Anuh Pharma generated ₹3 crore of cash from operations and spent ₹7.9 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹10.9 crore. In FY25 it was ₹17.2 crore.
What is the Anuh Pharma book value per share?
Anuh Pharma's book value per share was ₹35.14 on 31 March 2026: shareholders' equity of ₹352 crore divided by the 10.02 crore shares in issue. The share price at the 29 October 2026 close was ₹79.74.
What is the Anuh Pharma dividend in 2026 and its record date?
In 2026, Anuh Pharma has declared one dividend: ₹1.50 with record date 5 August 2026.
What is the Anuh Pharma promoter holding?
Promoters held 71.80% of Anuh Pharma on 30 September 2026, unchanged from the previous quarter and down 0.02 percentage points from 71.82% a year earlier, according to the shareholding pattern filed with NSE.
What is the Anuh Pharma EPS?
Anuh Pharma's basic earnings per share (EPS) were ₹4.10 in FY26.
What are the Anuh Pharma latest quarterly results?
Anuh Pharma's latest results are for Q1 FY27 (April–June 2026), filed on 7 August 2026: consolidated net profit ₹11.4 crore, up 37.6% from ₹8.3 crore in Q1 FY26; revenue from operations ₹194 crore, up 3.9% year on year.
When are the Anuh Pharma next results?
Anuh Pharma will announce its Q2 FY27 results (July–September 2026) on Friday, 30 October 2026, the date of the board meeting it has notified to the exchanges.
What is the Anuh Pharma revenue and profit in FY26?
In FY26 (April 2025–March 2026), Anuh Pharma's consolidated net profit was ₹41 crore, down 13.3% from ₹47.4 crore in FY25, on revenue from operations of ₹772 crore (up 16.7%).
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.
